Jane Wu
Impact in
- Obstetrics and Gynecology top 2%
- Endometrial and Cervical Cancer Treatments
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 5
- Cancer Immunotherapy and Biomarkers 2
-
- Antifungal resistance and susceptibility 4
- Co-authors
- Corina E. Dutcus (4 shared papers)Matthew H. Taylor (4 shared papers)Daniel E. Stepan (4 shared papers)Vicky Makker (4 shared papers)Robert Shumaker (2 shared papers)Robert J. Motzer (4 shared papers)Chung‐Han Lee (3 shared papers)Drew Rasco (2 shared papers)
- Journals
- Annals of Oncology (5 papers)Journal of Clinical Oncology (3 papers)Annals of Allergy Asthma & Immunology (2 papers)The Journal of Clinical Pharmacology (2 papers)Clinical Rehabilitation (1 paper)
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
Jane Wu
33 papers receiving 1.3k citations
Jane Wu's Hit Papers
Peers
Comparison fields: 5 of 94
- Obstetrics and Gynecology 181
- Oncology 409
- Reproductive Medicine 99
- Cancer Research 131
- Infectious Diseases 164
Countries citing papers authored by Jane Wu
This map shows the geographic impact of Jane Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Wu more than expected).
Fields of papers citing papers by Jane Wu
This network shows the impact of papers produced by Jane Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Wu. The network helps show where Jane Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Jane Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer Hit paper breakdown → | 2020 | 366 |
| 2 | Phase IB/II Trial of Lenvatinib Plus Pembrolizumab in Patients With Advanced Renal Cell Carcinoma, Endometrial Cancer, and Other Selected Advanced Solid Tumors Hit paper breakdown → | 2020 | 313 |
| 3 | 2009 | 107 | |
| 4 | 1997 | 96 | |
| 5 | 1997 | 69 | |
| 6 | 1998 | 47 | |
| 7 | 1997 | 46 | |
| 8 | 2001 | 40 | |
| 9 | 2005 | 37 | |
| 10 | 2020 | 31 | |
| 11 | 2004 | 26 | |
| 12 | 2017 | 19 | |
| 13 | 1995 | 16 | |
| 14 | 2010 | 12 | |
| 15 | 2005 | 9 | |
| 16 | 2019 | 8 | |
| 17 | 2024 | 8 | |
| 18 | 2015 | 6 | |
| 19 | 2019 | 6 | |
| 20 | 2016 | 6 |
About Jane Wu
Jane Wu is a scholar working on Oncology, Infectious Diseases, Pulmonary and Respiratory Medicine, Public Health, Environmental and Occupational Health and Emergency Medicine, having authored 33 papers that have together received 1.3k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (4 papers), Renal cell carcinoma treatment (3 papers), Intensive Care Unit Cognitive Disorders (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Trauma and Emergency Care Studies (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), HIV/AIDS oral health manifestations (2 papers) and Endometrial and Cervical Cancer Treatments (2 papers). The work is most often cited by research in Obstetrics and Gynecology (181 citations), Oncology (409 citations), Reproductive Medicine (99 citations), Cancer Research (131 citations) and Infectious Diseases (164 citations). Jane Wu has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Corina E. Dutcus, Matthew H. Taylor, Daniel E. Stepan, Vicky Makker, Robert Shumaker, Robert J. Motzer, Chung‐Han Lee, Drew Rasco, Mark A. Klausner and David G. Lange. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Annals of Allergy Asthma & Immunology, The Journal of Clinical Pharmacology and Clinical Rehabilitation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.